Cargando…
Scaling the EVERREST of severe, early-onset fetal growth restriction
Severe, early-onset fetal growth restriction is a leading cause of medically indicated preterm birth and substantially increases the risk for perinatal death or disability. No treatments exist to improve fetal growth or safely prolong pregnancy. Furthermore, wide-ranging phenotypes limit the accurat...
Autor principal: | Su, Emily J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503793/ https://www.ncbi.nlm.nih.gov/pubmed/37712422 http://dx.doi.org/10.1172/JCI173563 |
Ejemplares similares
-
EVERREST prospective study: a 6-year prospective study to define the clinical and biological characteristics of pregnancies affected by severe early onset fetal growth restriction
por: Spencer, Rebecca, et al.
Publicado: (2017) -
Early onset fetal growth restriction
por: Dall’Asta, Andrea, et al.
Publicado: (2017) -
Placental pathology in early-onset fetal growth restriction: insights into fetal growth restriction mechanisms
por: Bujorescu, Daniela-Loredana, et al.
Publicado: (2023) -
Pregnant women’s experiences and perceptions of participating in the EVERREST prospective study; a qualitative study
por: Harvey, Merryl E., et al.
Publicado: (2019) -
Assessment of fetal modified myocardial performance index in early‐onset and late‐onset fetal growth restriction
por: Zhang, Lina, et al.
Publicado: (2019)